Rentschler Biopharma SE
About Rentschler
Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO), focused exclusively on client projects. From its headquarters in Laupheim, Germany, and its site in Milford, MA, USA, Rentschler Biopharma offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. In order to offer best-in-class formulation development along the biopharmaceutical value chain, the company has entered a strategic alliance with Leukocare AG. Rentschler Biopharma is a family-owned company with 1.000 employees.
Advertisement
Product portfolio of Rentschler
News about Rentschler
Here you will find Rentschler Biopharma SE
Last viewed contents
Novozymes Biopharma Signs License Agreement with GE Healthcare to Produce and Sell Protein A
Biotech has Positive Year Despite Weak Fourth Quarter Performance - Burrill looks back at 2007
Nanoscale ruler reveals organization of the cell membrane - Freiburg biologists measure distances and the arrangement of membrane molecules in nanometer range
Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018
Tripos to Build One of the Leading Informatics-Driven Drug Discovery Laboratories in Europe - - State-of-the-Art Chemical Synthesis Facilities to be Built in Cornwall, England -
5 Leading Multinationals Announce R&D Projects for Ireland - Bristol-Myers Squibb Company, Pfizer Inc., Genzyme Corporation, Xilinx Inc. Citigroup are investing a total of EUR 53.25 million
Pesticides and other common chemical pollutants are toxic to our ‘good’ gut bacteria
Munich-based lab automation startup raised €2.77M - AI-driven biotech research: Connected labs for faster scientific progress
How machine learning, data integration and AI contribute to better strategies in the fight against pathogens - Researchers develop a new machine learning approach
Gene_therapy
Adapting the Power of Density Gradient Separations for Gene Therapy Analytics - DGE-AUC (Density Gradient Equilibrium AUC) highly simplified analytical method
